Canada Peptide Guide
Home › Healing & recovery › TB-500 and Thymosin Beta-4
Healing & recovery

TB-500 and Thymosin Beta-4

Not authorized in Canada Evidence 1/4
TB-500 and Thymosin Beta-4 peptide structure illustration (abstract amino-acid chain)
In short

TB-500 is a synthetic fragment of thymosin beta-4, a natural repair-related peptide. Eye-drop forms of Tβ4 have been in human trials; we found no human trials of TB-500. Not authorized in Canada.

Reviewed November 10, 2026 · 6 sources cited below

Also known asTβ4; TB-500 is a synthetic fragment
Canada statusNot authorized in Canada
Human evidence Very limited: almost all animal or cell studies (TB-500); small trials of Tβ4 eye drops
Sport (WADA)TB-500 and thymosin beta-4 are prohibited by WADA at all times (S2).
Last reviewedNovember 10, 2026

How strong is the human evidence?

Very limited: almost all animal or cell studies (TB-500); small trials of Tβ4 eye drops. How we rate evidence

What is TB-500 and Thymosin Beta-4?

Thymosin beta-4 (Tβ4) is a natural peptide involved in cell movement and tissue repair.

TB-500 is a synthetic version of an active region of Tβ4. Detection methods for it in racehorses were published in 2012.

What the research shows

  • Tβ4 eye drops (RGN-259): a small Phase 2 randomized trial in severe dry eye reported improved signs and symptoms (Sosne et al., Cornea 2015).
  • A Phase I study of recombinant Tβ4 in healthy volunteers was published in 2021.

What it doesn't show

  • We found no published human trials of TB-500 for injuries, muscle or recovery.
  • Eye-drop results for Tβ4 say nothing about injected TB-500.

Common questions

Is TB-500 the same as thymosin beta-4?

No. TB-500 is a synthetic fragment based on part of Tβ4.

Is TB-500 legal in Canada?

No. Health Canada lists it among unauthorized injectable peptides.

BPC-157 vs TB-500?

Both are unauthorized in Canada, both are banned in sport, and neither has convincing human evidence for healing injuries.

Sources

  1. Health Canada — Peptides: Overview
  2. Health Canada advisory RA-81874 (Apr 9, 2026): Think twice before injecting peptides bought online
  3. Ho EN et al. Doping control analysis of TB-500 in equine urine and plasma. J Chromatogr A 2012
  4. Sosne G et al. Tβ4 improves severe dry eye in a phase 2 randomized trial. Cornea 2015
  5. Wang X et al. First-in-human phase I study of recombinant Tβ4. J Cell Mol Med 2021
  6. World Anti-Doping Agency — Prohibited List

Related

BPC-157 peptide illustrationBPC-157The most-searched "healing peptide". Animal studies are plentiful, but a 2026 systematic review found only 3 tiny human…Not authorized in CanadaThymosin Alpha-1 peptide illustrationThymosin Alpha-1An immune-modulating peptide (thymalfasin) studied in infections, cancer and COVID-19. Meta-analyses disagree on…Not authorized in Canada (approved elsewhere)